1. Antitumor Activity and Mechanism Study of Riluzole and Its Derivatives
- Author
-
Wu, Xiang-Long, Liu, Liu, Wang, Qing-Chuan, Wang, Hai-Fang, Zhao, Xiang-Rong, Lin, Xu-Bin, Lv, Wen-Jun, Niu, Yin-Bo, Lu, Ting-Li, and Mei, Qi-Bing
- Subjects
Benzothiazole derivatives ,Synthesis ,Riluzole ,Antitumour activity ,Original Article ,Mechanism - Abstract
To explore novel antitumor agents with high efficiency and low toxicity, riluzole alkyl derivatives (4a-4i) were synthesized. Their anti-proliferative activities against HeLa, HepG2, SP2/0, and MCF-7 cancer cell lines were assessed by the CCK-8 assay and compared with human normal liver (LO2) cells. Most of them showed potent cytotoxic effects against four human tumor cell lines and low toxic to LO2 cells. In particular, 2-(N-ethylamine)-6-trifluoromethoxy- benzothiazole (4a) showed a IC50 value of 7.76 μmol/L in HeLa cells and was found to be nontoxic to LO2 cells up to 65 μmol/L. Furthermore, flow cytometry indicated that 4a could induce remarkable early apoptosis and G2/M cell cycle arrest in HeLa cells. It also impaired the migration ability of HeLa cells in wound healing assays. Western blot results demonstrated that 4a suppressed Bcl-2 protein expression but increased the level of Bax in HeLa cells, and elevated the Bax/Bcl-2 expression ratio. These new findings suggest that 4a exhibited beneficially anti-cervical cancer effect on HeLa cells by inducing HeLa cell apoptosis.
- Published
- 2020